Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, Giovanni de Simone, Erwan Donal, Thomas Kahan, Giuseppe Mancia, Josep Redon, Roland Schmieder, Bryan Williams, Enrico Agabiti-Rosei

Research output: Contribution to journalArticlepeer-review

Abstract

Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.

Original languageEnglish
Pages (from-to)945-960
Number of pages16
JournalEuropean Heart Journal Cardiovascular Imaging
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Keywords

  • Journal Article

Fingerprint

Dive into the research topics of 'Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)'. Together they form a unique fingerprint.

Cite this